惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Google DeepMind News
Google DeepMind News
L
LangChain Blog
H
Help Net Security
博客园_首页
T
Tailwind CSS Blog
Microsoft Security Blog
Microsoft Security Blog
T
The Blog of Author Tim Ferriss
雷峰网
雷峰网
Recent Announcements
Recent Announcements
D
DataBreaches.Net
U
Unit 42
Vercel News
Vercel News
I
InfoQ
Martin Fowler
Martin Fowler
Microsoft Azure Blog
Microsoft Azure Blog
Apple Machine Learning Research
Apple Machine Learning Research
S
SegmentFault 最新的问题
Jina AI
Jina AI
博客园 - 叶小钗
博客园 - 【当耐特】
罗磊的独立博客
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
月光博客
月光博客
Last Week in AI
Last Week in AI

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Medicover AB (publ) (MCVEY) Q1 2026 Earnings Call Transcript
SA Transcripts · 2026-04-30 · via All Articles on Seeking Alpha

Medicover AB (publ) (MCVEY) Q1 2026 Earnings Call April 29, 2026 3:30 AM EDT

Company Participants

John Stubbington - Chief Executive Officer
Anand Patel - Chief Financial Officer

Conference Call Participants

Philip Ekengren - ABG Sundal Collier Holding ASA, Research Division
Mattias Vadsten - SEB, Research Division
Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Kane Slutzkin - Deutsche Bank AG, Research Division
Darius Saftoiu - Jefferies LLC, Research Division

Presentation

Operator

Welcome to the Medicover Q1 2026 Report Presentation. [Operator Instructions]

Now I will hand the conference over to the speakers, CEO, John Stubbington; and CFO, Anand Patel. Please go ahead.

John Stubbington
Chief Executive Officer

Good morning, everybody. Welcome to our Q1 presentation. I think we've had a good first quarter. It's been a consistent and solid sort of position. We've got good momentum going on in the business with strong organic growth of 10.3%. This is our fifth consecutive quarter of improved margins year-on-year, which we're delighted with. There's been a few negative headwinds that have hit us. I don't think we need to talk about that too much. I think as a team, we've sort of navigated that well. And it shows the strength of our model. So it's pleasing to see the position that we've come out with despite all of that.

India, India has shown some strong momentum. We expected that. We talked about that a lot in previous quarters in terms of what we've done to be able to get a bigger level of growth and more momentum as we go towards IPO. So we're very positive with that particular result in the quarter, and we fully expect it to progress as we go through coming quarters.

Very robust performance in Diagnostic Services, very pleased for the team, done an excellent job and our fee-for-service development is increasing in